May 30, 10:00 PM – May 31, 3:00 AM (UTC)
The annual Melanoma Research Foundation (MRF) Breakthrough Consortium meeting will be held in conjunction with ASCO on Friday, May 30th, 2025, at the Hyatt Regency McCormick Place - Chicago in the Prairie Room (Second Floor). Event time 5:00PM to 10:00PM CT.
*Note: The event time above and event time in the agenda below, are automatically displayed in your current time zone. Thank you.
RSVP
Established in 2010, the MRFBC is a national network of 30 centers of excellence in melanoma that collaborate to accelerate the research and development of the most promising therapies in melanoma treatment in order to deliver curative options to patients. The Consortium institutions have a demonstrated track record of receiving NIH/peer-reviewed funding for multidisciplinary research in melanoma, publications in major medical journals, presentations at the major cancer and melanoma meetings, clinical trial expertise and patient care.
This year's meeting will highlight exciting research updates from MRFBC members, including those from newly joined institutions. The meeting will also feature translational studies and collaboration opportunities presented by industry partners.
John Hopkins Medicine
Professor of Biochemistry and Molecular Biology
John Hopkins Medicine
Assistant Professor of Oncology
Mayo Clinic
Professor of Immunology
Mayo Clinic
Surgical Oncologist, Professor of Surgery
MD Anderson Cancer Center
Assistant Professor Department of Immunology & Division of Discovery Science
UVA Comprehensive Cancer Center
Associate Professor, Medicine: Hematology and Oncology
The Angeles Clinic
Chief, Translational Research and Immunotherapy & Director, Melanoma Therapeutics
Immunocore
Vice President, Global Clinical Development
Replimune
Senior Vice President, Clinical Development
Melanoma Research Foundation
Board Chair
Melanoma Research Foundation
CEO
Northwell Health Cancer Instittue
Deputy Physician-in-Chief & Director of Medical Oncology
Massachusetts General Hospital
Director, Center of Melanoma at Mass General Hospital & Associate Professor of Medicine at Harvard Medical School
Melanoma Research Foundation
Chief Scientific Officer
May 30 – 31, 2025
10:00 PM – 3:00 AM (UTC)
| Welcome Reception |
| MRFBC Steering Committee Welcome |
| MRF Welcome |
| Impact of Research & Recent Team Science Award Update |
| 2025 DoD Melanoma Research Program (MRP) |
| Novel Translational Strategies and Access Innovations for Difficult-to-Treat Melanomas |
| Primary Cutaneous Melanoma Immune Subversion of Regional Lymph Nodes via Lymphatic Cargo |
| University of Virginia Multidisciplinary Melanoma Program |
| Defining the Immune Microenvironment of Checkpoint Inhibitor-Induced Immune-Related Adverse Events in the Skin of Melanoma Patients |
| The Angeles Clinic Presentation & Discussion |
| BREAK |
| Immunocore Presents: Clinical Need to Platform Hallmarks: Insights to Guide T Cell Engager Combination Strategies in Cutaneous Melanoma |
| Replimune Presentation & Discussion |
| MRFBC Steering Committee Closing Remarks |
| Dessert, Drinks & Networking |
Contact Us
